You just read:

Argos Therapeutics Presents Data Showing Memory T Cell Expansion After Administration of Fully Personalized Immunotherapy Correlates with Overall Survival Benefit in Patients with Metastatic Renal Cell Carcinoma

News provided by

Argos Therapeutics Inc.

Nov 11, 2013, 09:00 ET